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Purified cytochrome b,,, from guinea pig macrophages was rehpidated with several phosphohpid mixtures. Reliptdated cytochrome b,,, was found 
capable of NADPH-dependent superoxide (02J production in the absence of the cytosolic components of the NADPH oxidase complex. The rate 
of O,- generation by cytochrome b559 varted with the type of phospholipid utilized for rehpidation, was absolutely dependent on exogenous FAD, 
and was enhanced by a critical concentration of anionic amphiphile. It is demonstrated that exogenous FAD acts by binding to cytochrome b,,,. 
These results provide firm experimental evidence for the proposal that cytochrome b,,, comprises the complete electron transporting apparatus 
of the 02- forming NADPH oxidase and that the cytosolic components function merely as activators. 
Superoxide: Cytochrome bsT9; NADPH oxidase; Phospholiprd; Phosphatidic acid; FAD 
1. INTRODUCTION 
Phagocytes possess an enzyme complex catalyzing 
the one electron reduction of molecular oxygen to su- 
peroxide (0,J in conjunction with oxidation of 
NADPH [l]. The O,- forming NADPH oxidase is dor- 
mant in resting cells and is activated by various stimu- 
lants interacting with membrane receptors. Analysis of 
the constituents of NADPH oxidase was facilitated by 
the development of a cell-free system in which O,- pro- 
duction is elicited in mixtures of plasma membranes and 
cytosol, derived from resting cells, by anionic am- 
phiphiles, such as arachidonate [2] or SDS [3]. Four 
proteins were found to be required for O?- production 
in the cell-free system: cytochrome b,,,, which was 
shown to be the only component contributed by the 
membrane [4]; two cytosolic proteins, p47-phox and 
p67-phox [5,6], and the small G protein racl p21 [7] or 
rac2 p21 [8], also localized in the cytosol. It is commonly 
accepted that cytochrome b,,, is the terminal NADPH 
oxidase component, with its heme prosthetic group act- 
ing as the electron carrier to oxygen [lo]. A dissident 
view, questioning the redox function of cytochrome b,,, 
heme has also been expressed [l 11. Theoretical consider- 
ations and experimental findings also indicated that an 
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FAD-containing flavoprotein is a component of the ox- 
idase and, most likely, bears the NADPH binding site 
[12-141. The original suggestion that the NADPH-bind- 
ing flavoprotein was represented by one of the cytosolic 
factors [15] was contradicted by experimental evidence 
[ 161. On the other hand, the proposal that a membrane- 
bound flavoprotein is an obligatory component of the 
NADPH oxidase [17-211 is difficult to reconcile with 
the finding that the only membrane protein required for 
02- production in the cell-free system is cytochrome bss9 
[4] and with the complete reconstitution of the NADPH 
oxidase complex from purified cytochrome b,,, and pu- 
rified or recombinant cytosolic components [22,23]. 
Recently, the idea was put forward that cytochrome 
b,,, is a flavoprotein, the large subunit of which con- 
tains both the FAD and the NADPH-binding sites 
[22,24,25]. This hypothesis is based principally on the 
observation that alignment of the amino acid sequence 
of the large subunit of cytochrome b,,, with flavopro- 
teins of the ferredoxin-NADP’ reductase family reveals 
similarities in the NADPH and FAD-binding domains. 
The experimental evidence in support of this proposal 
is still rather limited and rests on the following findings. 
(1) Testing cytochrome b,,, for its ability to support 
cell-free O,- production demonstrated that dependence 
on exogenous FAD increased in parallel with the degree 
of cytochrome b,,, purity [25]. (2) Deflavinated cyto- 
chrome could be partially reflavinated, when FAD was 
added during NADPH oxidase assembly [22]. (3) The 
large subunit of cytochrome b,,, could be photoaffinity 
labelled with NADP [24]. In the present study we dem- 
onstrate that purified cytochrome b,,, incorporated in 
a specific lipid environment is capable of NADPH and 
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FAD-dependent O,- production in the absence of the 
three cytosolic activators. 
2. MATERIALS AND METHODS 
NADPH oxtdatton in the presence of all the components of the cell- 
free 02- generatmg system [27]. SDS-PAGE was performed on a 
11.5% acrylamtde separating gel. according to Laemmli [?S], followed 
by silver staining under basic condtttons [29]. Protein concentrations 
were determmed by the method of Bradford [30], bovme gamma 
globuhn being used as standard. 
2.1 Lipid.7 and other chemicals 
The following lipids were obtained from Sigma (product numbers 
appear m brackets): L-a-phosphattdylchohne of the following types: 
II-S, from soybean, 14% (P 5638): IV-S, from soybean, 35% (P 3644); 
X-E, from egg yolk. 60% (P 5394), and r-a-phosphatidic acid, sodtum 
salt, from egg yolk lecithm. 98% (P 951 I). Common laboratory chem- 
icals were purchased from Sigma or Merck Reagents for SDS-PAGE 
were from Bto-Rad. Chromatography matertals were obtained from 
Pharmacta LKB Biotechnology. 
2.2. Purr$cutron of cytochrome b,,, 
Guinea pig peritoneal macrophages were obtained and the mem- 
brane fraction prepared as described before [4]. Cytochrome b,, was 
purified essentially as descrtbed by us in the past [4], wtth some mod- 
ifications, Brtefly. the membrane pellet was extracted wtth I M NaCl 
and sohtbilized. at 223 x 108 cell equtvalents/ml, in buffer A (0.05 M 
sodium phosphate. pH 7.4, 1 mM MgCl:. 1 mM EGTA, 2 mm NaN,. 
1 mM dithtoerythrttol. 1 mM PMSF, 20% glycerol) containing 40 mM 
octyl glucoside. The soluble membrane fraction was batch-absorbed 
with DEAE-Sepharose CL 6B and the material not bound by the 
anion exchanger was supplemented with 0.05 M NaCl and diluted to 
30 mM octyl glucoside before being applied to a column of heparm- 
agarose. The column was washed wtth buffer A, contammg 30 mM 
octyl glucoside and supplemented with 0.1 M NaCI, and cytochrome 
b,,, eluted by a gradient of NaCl(O.1 to 0.7 M). As a final step in the 
purification sequence. we used gel filtration on a Superose 12 column 
(HR 10/30) in buffer A containmg 30 mM octyl glucoside and 150 mM 
NaCI, as described before [26]. The concentration of cytochrome hi,, 
was determined from the difference spectrum of sodtum dtthiomte- 
reduced rnrnu~ oxtdtzed samples, using the extinctton coefhctent 
(427-411 nm) = 200 mM_‘cm-’ [13]. The spectra were recorded and 
stored in the memory of a Uvikon 860 spectrophotometer (Kontron). 
3. RESULTS AND DISCUSSION 
The purified preparations of cytochrome h,,, utilized 
in the experiments described in this report had a heme 
content in the range of 7712 nmol/mg protein. SDS- 
PAGE analysis, utilizing silver staining. of typical cyto- 
chrome b,,, preparations demonstrated that these were 
free of contaminating proteins (Fig. 1). 
Purified cytochrome h,,, was relipidated with a vari- 
ety of phospholipids, essentially as described before 
[4.26] but exogenous FAD (1 PM) was present during 
all stages of the relipidation procedure. As apparent 
from Fig. 2 (panel A), relipidated cytochrome generated 
O,- upon additon of NADPH, in the absence of cytosol. 
The rate of 02- production was determined by the na- 
ture of the phospholipid utilized for relipidation. Thus. 
maximal 02- production was obtained when cyto- 
chrome h55q was relipidated with a mixture of a crude 
preparation of soybean phospholipids (14% phosphati- 
dylcholine) and 98% pure phosphatidic acid. Significant 
amounts were also produced by cytochrome h,,, relipi- 
kDa 
2.3. Recomtltutlon qf qvochrotne b,,, n.ltlz phosphohpld~ 
Phosphohptds were dtssolved in buffer A, containing 40 mM octyl 
glucoside at a concentration of 4 mg/ml. Occastonally. solubilization 
of lipids was assisted by somcation. Cytochrome h,,, preparations. 66 ~ 
derived from gel filtration on Superose 12 were supplemented with the 
desired amounts of phosphohptd and kept m ice for a few minutes. We 
+ LARGE 
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have shown that, for use in cell-free Oz- productton, cytochrome 
h,,,&pid-detergent mixtures have to be dtluted in or dtalyzed against 
detergent-free buffer. to reduce the concentration of octyl glucoside 
to 8 mM or less [4,26]. In the expertments described m thts report, the 
cytochrome h,,,phosphohptd mixtures were diluted 6 to &fold. m OZ- 
assay buffer (see below), lacking cytochrome c. and allowed to stand 
in ice for at least 30 min. 
45 - 
36 - 
2 4. O,- productron 
This was assayed by the rate of SOD-mhibitable cytochrome c 
reduction, as described before [3]. The assay buffer consisted of 65 mM 
K,Na-phosphate buffer, pH 7.0, 1 mM MgCI,. 1 mM EGTA, 2 mM 
NaN, and 0.1 mM ferrtcytochrome L’ Additional ingredients, when 
added, are indicated m the text and legends to figures. Measurements 
were performed wtth a Uvikon 860 spectrophotometer (Kontron) 
using a ‘ttme drive’ program. 




Measurements of NADPH-dependent reductton of cytochrome b55,, 
were performed under anaerobtc conditions that were achieved by 
bubbhng of nitrogen and an internal oxygen scavengmg system (100 
mM glucose and 2.66 units/ml glucose oxidase) The establishment of 
true anaerobic condittons was demonstrated by the virtual absence of 
1 2 3 
Fig. 1. SDS-PAGE of purified cytochrome b,,, preparations. Lane 1 
contains molecular weight standards. Lanes 2 and 3 contam distinct 
batches of purified cytochrome h,,,. 8 pmol of each batch were applied 
per lane. Arrows mdtcate the posttion of the two subumts of the 
cytochrome h,,, heterodtmer. 
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Fig. 2. 02- production by cytochrome b,,, m the absence of cytosolic activators. Purified cytochrome b559 (8.1 nmol/mg protein) was concentrated 
by ultrafiltration to 808 pmollml and reconstituted, as described m section 3, with the following phospholiptds: phosphatidylchohne, type II-S and 
phosphatidic and (100 &ml of each, tracings a); phosphatidylcholine. type II-S (200 &ml, tracings b); phosphatidtc acid (200 pg/ml, tracings 
c); phosphatidylcholine. type IV-S (200&ml, tracings d); and phosphatidylchohne. type X-E (200,&ml, tracings e). The cytochromeelipid mixtures 
were supplemented with 1 ,uM FAD, diluted 7 4-fold m assay buffer lacking cytochrome c and supplemented with 1 PM FAD and 30 ,KM LDS, 
and allowed to stand for 30 mm m ice. (A) At the time indicated by arrow marked 1. 2.2 pmol (in 20 ~1) of the various relipidated and diluted 
cytochrome b,,, preparations were added to cuvettes contaming 1.1 ml complete assay buffer containing 1 ,uM FAD, 30 FM LDS and 400 PM 
NADPH. At times indicated by arrows marked 2, 100 units/ml SOD were added. (B) Identical preparations of relipidated cytochrome h,,, were 
used. Arrows marked 1 indicate the addition of the cytochrome b,,, preparations. At times Indicated by arrows marked 2. 25 ,~l of macrophage 
cytosol (3.7 x lo6 cell equivalants) were added and the concentration of LDS was raised to 100 PM. At times indicated by arrows marked 3, 100 
units/ml SOD were added. 
dated with each of the above lipids, by itself. Lower 
amounts of O,- were generated by cytochrome b,,, re- 
lipidated with a soybean phospholipid preparation con- 
taining 35% phosphatidylcholine or an egg yolk phos- 
pholipid preparation containing 60% phosphati- 
dylcholine. The identification of the reaction product as 
O,- is proven by the complete inhibition of cytochrome 
c reduction by SOD (Fig. 2, panel A. arrow 2). 02- 
production was absolutely dependent on NADPH. 
LDS (optimal concentration = 30 ,uM) enhanced O,- 
production 1.552-fold but cytochrome bsg9 was also ca- 
pable of O,- generation in the absence of an anionic 
amphiphile. O,- generation by crude and purified cyto- 
chrome b,,, preparations, expressed as turnover rates 
(mol O,-/mol cytochrome b,&), is summarized in 
Table I. The value of close to 25 mol O,-/mol cyto- 
chrome b,,,ls, detected with purified cytochrome b,,, 
relipidated with the optimal phospholipid combination, 
Table I 
0; production by cytochrome h,,, in the absence of cytosohc activators 
0; production 
(mol O;/mol cytochrome b&s) 
Phosphohptd preparation Crude cytochrome b,,, 
(0.52 nmol/mg protein) 
-LDS +LDS 
Purified cytochrome b,,, 
(7712 nmol/mg protein) 
-LDS +LDS 
Phosphatidylchohne, type II-S + Phosphattdtc acid 11.5 f 4.9 (n = 2) 16.2 ? 1.2 (n = 3) 11.8 f 2.8 (n = 2) 23.8 + 4.8 (n = 4) 
Phosphatidylcholine. type II-S 4.3 f 1.8 (n = 3) 9.9 * 2.4 (n = 3) 12.2 
Phosphatidic acid 7.3 9.1 12.5 
Phosphatidylcholine, type IV-S 1.5f0.5(n=2) 5.1 2 1.0 (n = 6) 6.0 
Phosphatidylcholine, type X-E 2.4 2.5 
Cytochrome bsx9 preparations were reconstituted with phospholipids, as described m section 2 (200 pg/ml. when a single lipid was used and 100 
,@ml for each lipid, when two lipids were used in combination). The relipidated cytochrome b 559 preparations were assayed for 02- productton 
in the presence of 1 ,uM FAD and 400 PM NADPH but m the absence of cytosol. When added, the concentration of LDS was 30 PM. ‘n’ in 
parentheses indicates the number of cytochrome b 559 preparations tested. Results represent means ? SD. 
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Fig 3. Dependence of 02- production on exogenous FAD. Purified 
cytochrome b,,, was reconstituted with a mtxture of phosphati- 
dylcholine, type II-S and phosphattdtc actd. m the absence of ex- 
ogenous FAD. and O,- production was assayed. essentially as de- 
scribed m the legend of Fig. 2, in the presence of various concentra- 
ttons of FAD added to the assay medtum 
corresponds to 15-20% of the rates measured in am- 
phiphile-activated cell-free systems composed of puri- 
fied guinea pig cytochrome b,,, [4] or porcine cyto- 
chrome h59 [25] and cytosolic activators. The rates 
measured are close (70~80%) to those recently reported 
for fatty acid stimulated O,- production by porcine cy- 
tochrome b,,, combined with a membrane-derived ni- 
troblue tetrazolium reductase and cytosol [31] and 
about 30-fold higher than those reported for cyto- 
chrome b,,, combined with hepatic NADPH-cyto- 
chrome P450 reductase, in the absence of cytosol and 
amphiphile [32]. Cytosol-independent O,- production 
was evident with both crude and highly purified cyto- 
chrome hS,, preparations (Table I). The apparently 
lower turnover values found with crude cytochrome h,,, 
preparations represent a calculation artefact due to the 
presence of hemoproteins other than cytochrome b,,, in 
partially purified preparations and was observed before 
by us [4] and Sumimoto et al. [25]. Addition of cytosol 
to preparation of relipidated cytochrome h,,, engaged 
in NADPH-dependent O,- production resulted in an 
enhancement in the rate of 02- generation (Fig. 2. panel 
B). However. the enhancing effect of cytosol required 
the addition of LDS and exhibited a higher LDS con- 
centration optimum (100 PM, as opposed to 30 PM 
found with cytochrome b559 alone). Cytosol-enhanced 
O,- production was not related to the nature of the 
phospholipid used to reconstitute cytochrome b,,,, the 
only exception being the inability of cytosol to enhance 
_:!/I:.--- 
? I 1 2 
Fig 4. Preincubation of cytochrome b 5c9 with FAD enhances its abthty 
to generate 02-. Cytochrome h,,, was reconstttuted with a mixture of 
phosphatidylchohne. type II-S and phosphattdic acid m the absence 
of FAD and 02- production assayed essentially as described in the 
legend of Fig. 2. (Tracing a) To the cuvette contaming 1.1 ml assay 
buffer supplemented wtth 30 PM LDS and 400 ,BM NADPH. FAD 
was added to a final concentration of 1 nM followed by the addition 
of 3 pmol cytochrome hji, (arrow 1). At the time mdtcated by arrow 
3, further FAD was added, to brmg its final concentration of 0.49pM. 
(Tracmg b) 3 pmol of cytochrome b,,, was mrxed wtth 55 nM FAD 
and preincubated for 1 mm at room temperature. The mixture was 
added to the cuvette containing 1.1 ml assay buffer supplemented with 
30 PM LDS and 400 PM NADPH at the time indicated by arrow 1. 
The final concentration of FAD (dertved from the cytochrome h,,,- 
FAD preincubation mtxture) was I nM. At the time Indicated by 
arrow 2. FAD was added, to bring its tinal concentration to 0.49,~M. 
O,- production by cytochrome relipidated with 
phosphatidic acid (Fig. 2, panel B, tracing c). Relipi- 
dated cytochrome b,,, exhibited a substrate specificity 
similar to that measured in the presence of cytosolic 
activators [2,3]. with a Km of 75 PM, for NADPH and 
1.86 mM, for NADH. 
O,- generation by relipidated cytochrome b,,, was 
strictly dependent on exogenous FAD. As seen in Fig. 
3. half-maximal 02- production was achieved in the 
presence of 10 nM FAD. FMN was incapable of sup- 
porting OZ- production. The role of exogenous FAD in 
cell-free O,- production is the subject of controversy 
[22,24.25,31]. To clarify whether FAD functions as a 
cofactor of cytochrome b,,, or as a free electron carrier, 
experiments as that illustrated in Fig. 4 were performed. 
Tracing a represents 02- production by relipidated cy- 
tochrome b,,, added directly to the assay buffer supple- 
mented with 1 nM FAD (a concentration insufficient 
for supporting O,- production; see Fig.3). Tracing b 
represents O,- production by relipidated cytochrome 
b,,, preincubated with 55 nM FAD for 1 min before 
addition to the assay (this resulted in a final concentra- 
60 










Fig. 5. Reduction of purified and relipidated cytochrome h,,, by 
NADPH under anaerobic conditions Purified cytochrome b,,, (130 
pmol) relipidated with a mixture of phosphatidylcholine, type II-S and 
phosphatidic acid was added to a cuvette containing 0 7 ml of assay 
buffer supplemented with 1 PM FAD, 30 PM LDS and 140 units/ml 
of SOD. Anaerobic conditions were established. as described m sction 
2. and the absorbance spectrum of the oxidized cytochrome bx5,, was 
recorded (400-600 nm). This was followed by the addition of 400 PM 
NADPH and the absorbance spectrum recorded immediately after the 
addition of NADPH. Next, complete chemical reduction was induced 
by the addition of a few grains of sodium dithionite and the absorb- 
ance spectrum recorded again. Tracings represent the reduced minus 
oxidized difference spectra following the addition of NADPH (a) and 
sodium dithiomte (b). 
tion of 1 nM FAD in the assay buffer). It is apparent 
that preincubation with FAD leads to a higher rate of 
O,- production, approaching that measured following 
the addition of a saturating amount of FAD to the assay 
buffer (Fig. 4, arrow 2). This suggests the formation of 
a cytochrome b s59-FAD complex during preincubation. 
Finally, we investigated the capability of purified and 
relipidated cytochrome b,,, to interact with NADPH by 
examining whether NADPH can reduce cytochrome 
b,,, under anaerobic conditions. Fig. 5 illustrates the 
reduced minus oxidized spectrum of purified relipidated 
cytochrome b,,, incubated with NADPH under anaero- 
bic conditions in the presence of FAD and LDS (tracing 
a). Positive peaks were detected at 427 nm and 558 nm 
and a trough, at 412 nm. These values are characteristic 
of guinea pig cytochrome b,,, [4,33] and correspond 
precisely to those detected on the reduced minus oxi- 
dized spectrum of chemically reduced cytochrome b,,, 
(tracing b). 
We have demonstrated that cytochrome bssg incorpo- 
rated in an optimal lipid environment and supple- 
mented with FAD, shown to act by reflavinating the 
deflavinated apoprotein, is capable of NADPH-de- 
pendent 02- production. The presence of an anionic 
amphiphile, such as LDS, was not a prerequisite for O,- 
generation but had an enhancing effect. The mechanism 
by which relipidated cytochrome b,,9 becomes catalyti- 
cally active in the absence of cytosolic components re- 
mains to be clarified. We found that the ability of a 
particular preparation of phosphatidylcholine to sup- 
port cytochrome b,,,-mediated 02- production in- 
creased with the proportion of contaminating (= other 
than phosphatidylcholine) lipids that it contained. This 
suggests that, in addition to a structural role in provid- 
ing a membrane-mimicking environment, one or more 
of the lipids used in the relipidation procedure might 
function as activators, not unlike anionic amphiphiles 
in the complete (membrane+cytosol) cell-free system. 
Support for this suggestion is provided by the finding 
that the highest rates of O?- production were obtained 
with cytochrome b,,, relipidated with a mixture of the 
least pure preparation of phosphatidylcholine (type II- 
S) and phosphatidic acid. It is of interest that Bellavite 
et al. [33] described the ability of phosphatidic acid from 
egg yolk lecithin (the type of preparation also used in 
our experiments) to elicit O?- production in solubilized 
porcine neutrophil membranes independently of cy- 
tosol. The phosphatidic acid-activable material copuri- 
lied with cytochrome b,,, and O,- production was de- 
pendent on the presence of FAD in the assay medium. 
In conclusion, the present report offers direct experi- 
mental proof for the proposal [22,24,25] that the com- 
plete electron transporting machinery of the O,- gener- 
ating NADPH oxidase is contained in the cytochrome 
b,,, dimer. 
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